Drug makers are going beyond continuous improvement and green chemistry to increase the sustainability of small-molecule manufacturing. In the latest Intergovernmental Panel on Climate Change report ...

India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...

BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8.57% during the 2020-2026 phase. The Indian drug ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes-difficult-to-get drug. The ...

BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and ...

Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations.

Saneca Pharma is making significant investment in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up. Slovakia-based CDMO Saneca Pharma announced that it is ...

Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

Piramal Pharma Solutions (PPS), the contract development and manufacturing organisation of Piramal Pharma Ltd on Wednesday announced that it has entered into an agreement to acquire 100 per cent stake ...